Demonstrates efficient synthetic access to Nobilin D in bibenzyl products, indicating a scalable platform for future pharmacological research.
We report the first concise and efficient racemic total synthesis of (±)-Nobilin D, a bioactive bibenzyl natural product isolated from Dendrobium nobile. Our unified synthetic approach also provides access to (±)-Combretastatin, Moscatilin, and Erianin, all derived from a readily available bromoethyl-substituted norbornyl α-diketone precursor. The key steps involve a Grob fragmentation–aromatization sequence to yield a crucial aromatic ester intermediate, which is then subjected to Baeyer–Villiger oxidation, O-methylation, dehydrohalogenation, and epoxidation to generate highly substituted styrene epoxides. Subsequent regioselective aryl-organolithium epoxide opening, followed by Pd–C/H2 hydrogenolysis, enables the efficient assembly of all four target natural products. This work not only provides the first synthetic access to Nobilin D but also allows for unambiguous structure confirmation by X-ray crystallography. Furthermore, our strategy establishes a scalable platform for the preparation of pharmacologically relevant bibenzyl scaffolds, facilitating future structure–activity relationship (SAR) studies.
No takes yet. Share an insight, caveat, or question.
Sreenivas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: